Risk of Lymphoma in Patients With Asthma Treated With Dupilumab Compared With Other Biologic Agents: A Retrospective Cohort Study.

Liao KM, Huang SC, Kuo CY, Hsu WH, Tsai YW, Wu JY, Lai CC

Open source

DOI
10.1016/j.chest.2026.07.5213
Published
2026 Jul 28
Container
Chest
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.chest.2026.07.5213,
  title = {Risk of Lymphoma in Patients With Asthma Treated With Dupilumab Compared With Other Biologic Agents: A Retrospective Cohort Study.},
  author = {Liao KM and Huang SC and Kuo CY and Hsu WH and Tsai YW and Wu JY and Lai CC},
  year = {2026},
  journal = {Chest},
  doi = {10.1016/j.chest.2026.07.5213},
  url = {https://doi.org/10.1016/j.chest.2026.07.5213}
}

RIS

TY  - JOUR
TI  - Risk of Lymphoma in Patients With Asthma Treated With Dupilumab Compared With Other Biologic Agents: A Retrospective Cohort Study.
AU  - Liao KM
AU  - Huang SC
AU  - Kuo CY
AU  - Hsu WH
AU  - Tsai YW
AU  - Wu JY
AU  - Lai CC
PY  - 2026
JO  - Chest
DO  - 10.1016/j.chest.2026.07.5213
UR  - https://doi.org/10.1016/j.chest.2026.07.5213
ER  - 

APA

KM, L., SC, H., CY, K., WH, H., YW, T., JY, W., & CC, L. (2026). Risk of Lymphoma in Patients With Asthma Treated With Dupilumab Compared With Other Biologic Agents: A Retrospective Cohort Study.. Chest. https://doi.org/10.1016/j.chest.2026.07.5213

Source records